Please assess the completion status of the following clinical trial:

Trial Title: InSeal Vascular Closure Device Clinical Study Protocol

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Candidate for large bore catheterization procedure (such as TAVI, aortic endograft repair) using a CE approved 18Fr access sheath.~* Subject age is at least 18 years~* Patient has signed most recent approved version of the Informed Consent~* Existence of an additional arterial access port is required in instances where an occluding balloon is planned to be used as a safety precaution.~Exclusion Criteria:~* Women Of Child Bearing Potential (WOCBP)~* Legally non-competent patients~* Patient participating in another clinical study at the time of the InSeal VCD study~* Prior target artery closure with a vascular closure device having intravascular component (such as Angio-Seal) 30 days prior to catheterization~* Subjects with known coagulopathy, preexisting hematoma, arteriovenous fistula, or pseudoaneurysm at the vessel access site prior to artery closure~* Patients that do not tolerate aspirin and clopidogrel anticoagulation treatment~* Prior vascular surgery or vascular graft in region of access site~* Significant calcification, atherosclerotic disease, or stent within 1.5 cm of the puncture site that may interfere with the operation of the experimental device

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- InSeal's Vascular Closure Device (Type: EXPERIMENTAL): Use of the experimental VCD to close the access site of the artery

Based on this trial design, predict the completion outcome and termination type (if applicable).